Opus Genetics logo

Opus Genetics

Gene therapy company for inherited retinal diseases

42 employees · est. 2021 · Raleigh, United States

VS
UNITY Biotechnology logo

UNITY Biotechnology

33 employees · est. 2009 · South San Francisco, United...

UNITY Biotechnology is the older company (2021 vs 2009).

Side-by-Side Comparison

Opus Genetics UNITY Biotechnology
Founded
2021 2009 older
Headquarters
Raleigh, United States South San Francisco, United States
Employees
42 33
Industry
Health Care, Health and Wellness Biotechnology, Health Care
Funding Stage
Grant Post Ipo Debt
Total Funding
$20.70M $294.89M
Funding Rounds
2 8
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Gene Therapy, Inherited Retinal Diseases, Clinical-stage, Patient-first Approach, Opthamology, Start-up, Investor-backed, Foundation Fighting Blindness, RD Fund, Orphan Diseases Therapeutics, Diseases Of Aging, Senescent Cells, Age-related Ophthalmologic Diseases, Neurologic Diseases, Senolytic Medicines, Senolytic Therapy, Aging Research, Pharmaceuticals, Biomedical Innovations
Website
opusgtx.com unitybiotechnology.com
Opus Genetics logo

About Opus Genetics

Opus Genetics is a pioneering clinical-stage gene therapy company focused on orphan inherited retinal diseases, aiming to put patients at the forefront of their mission. Established in 2004, the company operates in the Health Care industry and is headquartered in the United States. Opus Genetics has...

UNITY Biotechnology logo

About UNITY Biotechnology

UNITY Biotechnology is a biotechnology company founded in 2009 and headquartered in the United States. Focused on harnessing pathways of aging biology, the company is dedicated to developing new medicines, with a specific emphasis on retinal diseases. As pioneers in cellular senescence, UNITY is at...

We will tell you when either one moves

BounceWatch watches Opus Genetics and UNITY Biotechnology for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Opus Genetics and UNITY Biotechnology — by email.

Frequently Asked Questions

Opus Genetics — Gene therapy company for inherited retinal diseases. UNITY Biotechnology. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Opus Genetics has raised $20.70M while UNITY Biotechnology has raised $294.89M.
Opus Genetics and UNITY Biotechnology operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Opus Genetics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Opus Genetics on 9 Jun 2026, and UNITY Biotechnology on 26 Feb 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy